PERIODONTITIS DIAGNOSTIC METHODS, USES AND KITS

    公开(公告)号:US20210164996A1

    公开(公告)日:2021-06-03

    申请号:US17046473

    申请日:2019-04-12

    IPC分类号: G01N33/68

    摘要: Disclosed is an in vitro method for assessing whether a human patient has periodontitis. The method is based on the insight to determine biomarker proteins. Accordingly, in a sample of saliva a patient suffering from periodontitis, the concentrations are measured of the certain protein combinations. One such combination is Alpha-1-acid glycoprotein (A1AGP) and at least one of Profilin and S100 calcium-binding protein A9 (S100A9). Another combination is Pyruvate Kinase (PK) and S100 calcium-binding protein A8 (S100A8). Based on the concentrations as measured, a value is determined reflecting the joint concentrations for said proteins. This value is compared with a threshold value reflecting in the same manner the joint concentrations associated with periodontitis. The comparison allows assessing whether the testing value is indicative of the presence of periodontitis in said patient. Thereby, typically, a testing value reflecting a joint concentration below the joint concentration reflected by the threshold value is indicative for absence of periodontitis in said patient, and a testing value reflecting a joint concentration at or above the joint concentration reflected by the threshold value, is indicative for periodontitis in said patient.

    PROPORTIONAL DIVISION OF A TOTAL OPERATION TIME OF A DENTAL CARE PROCEDURE

    公开(公告)号:US20220323186A1

    公开(公告)日:2022-10-13

    申请号:US17641028

    申请日:2020-08-28

    IPC分类号: A61C17/22 A46B15/00

    摘要: In the context of dental care, a system (100) is provided which comprises i) an appliance (110) that is configured to operate a functional unit, ii) a data providing arrangement (120) that is configured to include operation data in the form of respective combinations of a mouth area and an effective time duration of a dental care action for the area concerned, wherein the effective time durations of the respective combinations add up to a total operation time of a dental care procedure and have respective values according to a proportional division of the total operation time on the basis of a distribution of the extent to which dental care is needed at the areas of the respective combinations, and iii) a controller (130) that is configured to communicate with the data providing arrangement (120) and to control operation of the appliance (110) in accordance with the operation data.

    DIAGNOSTICS OF GINGIVITIS
    5.
    发明公开

    公开(公告)号:US20230393149A1

    公开(公告)日:2023-12-07

    申请号:US18236453

    申请日:2023-08-22

    IPC分类号: G01N33/68 G16H10/40

    摘要: Disclosed is an in vitro method for assessing the presence of gingivitis in a human subject. The method is based on the insight to determine a selection of three biomarker proteins. Accordingly, in a saliva sample of the subject the concentrations are measured of the proteins Hepatocyte growth factor (HGF) and Interleukin-1β (IL-1β), and at least one of C reactive protein (CRP) and Haemoglobin. Based on the concentrations as measured, a value is determined reflecting the joint concentrations for said proteins. This value is compared with a threshold value reflecting in the same manner the joint concentrations associated with the absence of gingivitis or periodontitis. The comparison allows to assessing whether the testing value is indicative of the presence of gingivitis in said subject. Thereby, typically, a testing value reflecting a joint concentration above the joint concentration reflected by the threshold, is indicative of the presence of gingivitis.

    CLASSIFICATION OF PERIODONTITIS PATIENTS

    公开(公告)号:US20210181209A1

    公开(公告)日:2021-06-17

    申请号:US16758902

    申请日:2018-10-18

    IPC分类号: G01N33/68

    摘要: Disclosed is a system, a kit, a use and an in vitro method for assessing whether a human patient suffering from periodontitis has mild periodontitis or advanced periodontitis. The system and method are based on the insight to apply a clustering technique to a reference set of patient data, and then further discriminating the sets of bio markers to be applied. The clusters are determined on the basis of the biomarkers Hepatocyte Growth Factor (HGF), Matrix metalloproteinase 8 (MMP8), and Matrix metalloproteinase 9 (MMP9). The actual classification of the patient is done on the basis of the measurement of the concentrations of either of two sets of biomarkers. For one cluster these are Interleukin-1β (IL1β), Interleukin-6 (IL6), and Collagen Telopeptide. For the other cluster, these are HGF and metallopeptidase inhibitor 1 (TIMP1).

    NON-INVASIVE PERIODONTAL EXAMINATION
    7.
    发明公开

    公开(公告)号:US20240296558A1

    公开(公告)日:2024-09-05

    申请号:US18572704

    申请日:2022-06-10

    IPC分类号: G06T7/00 G06T7/62

    摘要: A method for performing a non-invasive periodontal examination on a subject. The method comprises obtaining a first optical image of the surface of an intra-oral area of the subject, the intra-oral area containing at least one tooth and a corresponding gum and obtaining a second image of the intra-oral area of the subject, wherein the second image contains an image of the hard tissue covered by the soft tissue. The hard tissue includes bone and teeth. The method further comprises merging the optical image and the second image into a fused image such that the tooth and part of the gum in the fused image are based on the optical image and wherein any bone in the fused image is based on the second image and estimating the periodontal distance between a soft tissue landmark and a hard tissue landmark for each tooth in the intra-oral area based on the fused image.

    DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS

    公开(公告)号:US20210382069A1

    公开(公告)日:2021-12-09

    申请号:US17045312

    申请日:2019-04-02

    IPC分类号: G01N33/68 C12N9/12 B01L3/00

    摘要: Disclosed is an in vitro method for assessing whether a human patient suffering from periodontitis has mild periodontitis or advanced periodontitis. The method is based on the insight to determine a selection of three bio marker proteins. Accordingly, in a sample of saliva a patient suffering from periodontitis, the concentrations are measured of the proteins Pyruvate Kinase (PK) and at least two of Haemoglobin-beta (Hb-beta), Haemoglobin-delta (Hb-delta), S100 calcium-binding protein A8 (S100A8) and S100 calcium-binding protein A9 (S100A9). Based on the concentrations as measured, a value is determined reflecting the joint concentrations for said proteins. This value is compared with a threshold value reflecting in the same manner the joint concentrations associated with advanced periodontitis. The comparison allows assessing whether the testing value is indicative of the presence of advanced periodontitis or of mild periodontitis in said patient. Thereby, typically, a testing value reflecting a joint concentration below the joint concentration reflected by the threshold value is indicative for mild periodontitis in said patient, and a testing value reflecting a joint concentration at or above the joint concentration reflected by the threshold value, is indicative for advanced periodontitis in said patient.